Drug Type Synthetic peptide |
Synonyms Iseganan, Iseganan hydrochloride (USAN) + [3] |
Target- |
Mechanism Cell membrane modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC78H129ClN30O19S4 |
InChIKeyZYXRBIMTMVZFBC-KRDVWEALSA-N |
CAS Registry244015-05-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pneumonia | Phase 3 | US | 01 Sep 2003 | |
Pneumonia, Ventilator-Associated | Phase 3 | US | 01 Sep 2003 | |
Healthcare-Associated Pneumonia | Phase 3 | - | - | |
Hospital-acquired pneumonia | Phase 3 | EU | - | - |
Hospital-acquired pneumonia | Phase 3 | US | - | - |
Mycoses | Phase 3 | US | - | - |
Stomatitis | Phase 3 | - | - | |
Stomatitis | Phase 3 | US | - | - |
Stomatitis | Phase 3 | - | - | - |